Myostatin Human Recombinant
Myostatin Human Recombinant, HEK
Myostatin Human Recombinant, His Tag
Myostatin Propeptide Human Recombinant
Myostatin Propeptide Human Recombinant, HEK
Myostatin, also known as growth differentiation factor 8 (GDF8), is a secreted protein that belongs to the transforming growth factor-beta (TGF-β) superfamily . It is primarily known for its role as a negative regulator of skeletal muscle growth . Myostatin is classified under the TGF-β superfamily, which includes other growth and differentiation factors such as bone morphogenetic proteins (BMPs) and activins .
Key Biological Properties: Myostatin is a myokine produced and released by myocytes, acting on muscle cells to inhibit muscle growth . It is a secreted growth differentiation factor that is assembled and produced in skeletal muscle before being released into the bloodstream .
Expression Patterns and Tissue Distribution: Myostatin is predominantly expressed in skeletal muscle tissue, but it is also found in other tissues such as the heart and adipose tissue . Its expression is tightly regulated and is highest in muscles involved in locomotion and posture .
Primary Biological Functions: The primary function of myostatin is to inhibit muscle growth and differentiation . It plays a crucial role in regulating muscle mass by limiting the number and size of muscle fibers .
Role in Immune Responses and Pathogen Recognition: While myostatin’s primary role is in muscle regulation, it also has implications in immune responses. It can influence the immune system by modulating the activity of immune cells and cytokines .
Mechanisms with Other Molecules and Cells: Myostatin exerts its effects through both paracrine and endocrine modes of action . It binds to the activin type II receptor, leading to the recruitment of coreceptors such as Alk-3 or Alk-4 . This binding initiates a signaling cascade involving the activation of SMAD transcription factors, particularly SMAD2 and SMAD3 .
Binding Partners and Downstream Signaling Cascades: Upon binding to its receptors, myostatin activates downstream signaling pathways that inhibit muscle cell growth and promote protein degradation . It inhibits Akt-induced protein synthesis and stimulates ubiquitin-regulated protein degradation .
Regulation of Expression and Activity: Myostatin expression and activity are regulated at multiple levels, including transcriptional and post-translational modifications . Transcriptional regulation involves various transcription factors and promoter elements that control the gene’s expression .
Post-Translational Modifications: Myostatin undergoes several post-translational modifications, including proteolytic processing and glycosylation, which are essential for its activation and function .
Biomedical Research: Myostatin has significant applications in biomedical research, particularly in understanding muscle-wasting diseases and developing therapeutic strategies to counteract muscle loss .
Diagnostic Tools and Therapeutic Strategies: Myostatin inhibitors are being explored as potential treatments for conditions such as muscular dystrophy, cachexia, and sarcopenia . Diagnostic tools measuring myostatin levels can help in the assessment of muscle health and disease progression .
Development to Aging and Disease: Myostatin plays a critical role throughout the life cycle, from embryonic development to aging . During development, it regulates the formation of muscle fibers, while in adulthood, it maintains muscle homeostasis . Dysregulation of myostatin is associated with various muscle-related diseases and conditions, including muscle atrophy and hypertrophy .